GE HealthCare Technologies Inc. $GEHC Shares Acquired by Salem Investment Counselors Inc.

Salem Investment Counselors Inc. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 176,452 shares of the company’s stock after buying an additional 14,867 shares during the period. Salem Investment Counselors Inc.’s holdings in GE HealthCare Technologies were worth $14,473,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after acquiring an additional 3,949,361 shares in the last quarter. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares in the last quarter. State Street Corp raised its holdings in GE HealthCare Technologies by 1.9% during the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after purchasing an additional 372,755 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its position in GE HealthCare Technologies by 17.1% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after purchasing an additional 1,232,828 shares during the period. Finally, Norges Bank acquired a new stake in GE HealthCare Technologies in the second quarter worth approximately $468,120,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 2.9%

Shares of GEHC opened at $71.65 on Tuesday. The business’s 50-day moving average price is $78.91 and its 200 day moving average price is $78.45. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $32.69 billion, a P/E ratio of 15.71, a P/E/G ratio of 1.53 and a beta of 1.03. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Evercore lifted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Barclays upped their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Citigroup lowered their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a report on Wednesday, March 11th. Bank of America lifted their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $98.00 price target on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.